A Counteraction with the Stable Gastric Pentadecapeptide BPC 157 (PL 14736)
Against retinoids: GHK-Cu in the Abdulghani trial outperformed tretinoin without the irritation, peeling, and sun sensitivity that retinoids commonly cause
In order to detect a medium effect size of 0.625 (average accuracy increase of 0.08 and standard deviation of 0.128) for the primary outcome (MIFT accuracy), with an intra subject correlation of 0.3, a power of 80% a false positive rate set to 5%, and assuming a 30% dropout rate, the target sample size was 44 participants
Early intervention, ideally concurrent with chemotherapy rather than after nerve damage has become established, may provide better outcomes than delayed treatment
Worth noting Contains EU-listed fragrance allergens, including Hexyl Cinnamal and Linalool